BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20729722)

  • 1. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
    Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
    Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
    Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of early recurrent fetal loss and levels of thrombin-activatable fibrinolysis inhibitor.
    Legnani C; Bovara M; Valdrè L; Cosmi B; Caniato A; Palareti G
    Thromb Res; 2012 Aug; 130(2):237-41. PubMed ID: 22032800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.
    Vairaktaris E; Yapijakis C; Nkenke E; Vassiliou S; Vylliotis A; Nixon AM; Derka S; Ragos V; Spyridonidou S; Tsigris C; Neukam FW; Patsouris E
    Am J Hematol; 2007 Nov; 82(11):1010-2. PubMed ID: 17636471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
    Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
    Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
    Orikaza CM; Morelli VM; Matos MF; Lourenço DM
    Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
    Franco RF; Fagundes MG; Meijers JC; Reitsma PH; Lourenço D; Morelli V; Maffei FH; Ferrari IC; Piccinato CE; Silva WA; Zago MA
    Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss.
    Papazoglou D; Galazios G; Papatheodorou K; Liberis V; Papanas N; Maltezos E; Maroulis GB
    Fertil Steril; 2005 Apr; 83(4):959-63. PubMed ID: 15820807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.
    ElDanasori N; Abulata N; Shaheen IA; ElGendy AM; El-Khayat W
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):532-535. PubMed ID: 28301909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
    de Bruijne EL; Darwish Murad S; de Maat MP; Tanck MW; Haagsma EB; van Hoek B; Rosendaal FR; Janssen HL; Leebeek FW;
    Thromb Haemost; 2007 Feb; 97(2):181-5. PubMed ID: 17264944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [C677T polymorphism of the methylentetrahydrofolate reductase gene as risk factor in women with recurrent abortion].
    Morales-Machín A; Borjas-Fajardo L; Quintero JM; Zabala W; Alvarez F; Delgado W; Hernández ML; Solis-Añez E; Sánchez Yy; Butrón Z
    Invest Clin; 2009 Sep; 50(3):327-33. PubMed ID: 19961055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion.
    Fang P; Cai D; Du L; Shen F; Zhang C; Li M
    Clin Appl Thromb Hemost; 2021; 27():10760296211029720. PubMed ID: 34189940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.
    Chengwei X; Xiaoli M; Yuan Z; Li P; Shengjiang W; Chao Y; Yunshan W
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):698-703. PubMed ID: 23624357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.
    Mtiraoui N; Zammiti W; Ghazouani L; Braham NJ; Saidi S; Finan RR; Almawi WY; Mahjoub T
    Reproduction; 2006 Feb; 131(2):395-401. PubMed ID: 16452733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome.
    Martínez-Zamora MA; Creus M; Tassies D; Bové A; Reverter JC; Carmona F; Balasch J
    Fertil Steril; 2010 Nov; 94(6):2437-40. PubMed ID: 20378110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HLA-E *0101 homozygosity and recurrent miscarriage in Egyptian women.
    Mosaad YM; Abdel-Dayem Y; El-Deek BS; El-Sherbini SM
    Scand J Immunol; 2011 Aug; 74(2):205-9. PubMed ID: 21410502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.